About Aptamer Group
Aptamer Group is a company based in York (United Kingdom) founded in 2008.. Aptamer Group has raised $2.2 million across 5 funding rounds from investors including Gov.uk, SPARK Advisory Partners and Turner Pope Investments. Aptamer Group offers products and services including Optimer Platform and Optimer Binders. Aptamer Group operates in a competitive market with competitors including Aptamer Sciences, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
- Headquarter York, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aptamer Group Plc
-
Annual Revenue
$1.08 M (USD)-50.91as on Jun 30, 2024
-
Net Profit
$-3.71 M (USD)62.25as on Jun 30, 2024
-
EBITDA
$-3.72 M (USD)37.68as on Jun 30, 2024
-
Total Equity Funding
$2.2 M (USD)
in 5 rounds
-
Latest Funding Round
$2.73 M (USD), Post-IPO
Jul 04, 2025
-
Investors
Gov.uk
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aptamer Group
Aptamer Group is a publicly listed company on the LSE with ticker symbol APTA in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aptamer Group
Aptamer Group offers a comprehensive portfolio of products and services, including Optimer Platform and Optimer Binders. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for custom aptamer discovery and binding services.
High-affinity binders for therapeutic and diagnostic applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Aptamer Group
Aptamer Group has successfully raised a total of $2.2M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2.73 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $2.7M
-
First Round
First Round
(26 Jun 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Post-IPO - Aptamer Group | Valuation |
investors |
|
| Jul, 2024 | Amount | Post-IPO - Aptamer Group | Valuation |
investors |
|
| Sep, 2023 | Amount | Post-IPO - Aptamer Group | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aptamer Group
Aptamer Group has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, SPARK Advisory Partners and Turner Pope Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment opportunities in early-stage biotech and pharma are facilitated by Meneldor.
|
Founded Year | Domain | Location | |
|
Independent corporate finance advice is provided by SPARK Advisory Partners.
|
Founded Year | Domain | Location | |
|
Turner Pope Investments is engaged as a boutique stockbroker providing investment services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aptamer Group
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aptamer Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aptamer Group Comparisons
Competitors of Aptamer Group
Aptamer Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Sciences, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary aptamer technology is utilized for protein analysis.
|
|
| domain | founded_year | HQ Location |
Services for custom aptamer development
|
|
| domain | founded_year | HQ Location |
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
|
|
| domain | founded_year | HQ Location |
Aptamers are developed and provided via SELEX platform technology.
|
|
| domain | founded_year | HQ Location |
Aptamer-based biotechnological applications are developed for diverse uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aptamer Group
Frequently Asked Questions about Aptamer Group
When was Aptamer Group founded?
Aptamer Group was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Where is Aptamer Group located?
Aptamer Group is headquartered in York, United Kingdom.
Is Aptamer Group a funded company?
Aptamer Group is a funded company, having raised a total of $2.2M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $385K, raised on Jun 26, 2018.
What is the annual revenue of Aptamer Group?
Annual revenue of Aptamer Group is $1.08M as on Jun 30, 2024.
What does Aptamer Group do?
Aptamer Group was founded in 2008 in York, United Kingdom, and operates within the biotechnology sector. DNA and RNA aptamers are produced using Optimer technology, serving as alternatives to antibodies. These molecules are applied in research reagents, biomarker identification, diagnostic tools, and therapeutic development. Operations focus on nucleic acid-based binders for scientific and medical applications.
Who are the top competitors of Aptamer Group?
Aptamer Group's top competitors include Aptamer Sciences, Base Pair Biotechnologies and Apta Biotech.
What products or services does Aptamer Group offer?
Aptamer Group offers Optimer Platform and Optimer Binders.
Is Aptamer Group publicly traded?
Yes, Aptamer Group is publicly traded on LSE under the ticker symbol APTA.
Who are Aptamer Group's investors?
Aptamer Group has 4 investors. Key investors include Gov.uk, SPARK Advisory Partners, Turner Pope Investments, and Meneldor.
What is Aptamer Group's ticker symbol?
The ticker symbol of Aptamer Group is APTA on LSE.